GlaxoSmithKline Cash Flow Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 10,427.8 | 12,299.2 | 8,531.9 |
| Net Investing Cash Flow | (1,662.9) | (6,006.9) | (2,978.4) |
| Net Financing Cash Flow | (7,103.3) | (3,475.6) | (9,383.7) |
| Net Change in Cash | 1,661.5 | 2,816.8 | (3,830.2) |
| Depreciation & Amortization | 1,781.6 | 2,034.8 | 1,878.0 |
| Capital Expenditures | (2,079.8) | (3,026.4) | (2,674.9) |
| Cash Dividends Paid | (4,353.5) | (5,729.4) | (5,257.8) |
© 2009 Morningstar, Inc. Financial Data provided by
